Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis

International Journal of Medical Sciences

Volumn 4, Issue 2, 2007, Pages 59-71

  Kiyohara, Chikako ^a   Yoshimasu, Kouichi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Genetic polymorphism; Lung cancer; Meta analysis; Nucleotide excision repair

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLYCINE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DNA REPAIR; EXCISION REPAIR; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOSITY; HIGH THROUGHPUT SCREENING; HUMAN; LUNG CANCER; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW; XERODERMA PIGMENTOSUM;

EID: 33846923410     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.4.59     Document Type: Review

References (69)

1. Pharoah PD, Dunning A, Ponder BA, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004; 4: 850-60.
2. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes. Mutat Res 2005; 577: 275-83.
3. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968; 218: 652-6.
4. de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000; 21: 453-60.
5. Hanawalt PC. Subpathways of nucleotide excision repair and their regulation. Oncogene 2002; 21: 8949-56.
6. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JH. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In:Vogelstein B, Kinzler KW ed. The Genetic Basis of Human Cancer. New York: McGraw-Hill; 1998: 245-74.
7. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci (USA) 1997; 94: 11-4.
8. Lehmann AR. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 2003; 85: 1101-11.
9. Park JY, Park SH, Choi JE, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 993-7.
10. Wu X, Zhao H, Wei Q, et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003; 24: 505-9.
11. Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004; 25: 2433-41.
12. Vogel U, Overvad K, Wallin H, et al. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer. Cancer Lett 2005; 222: 67-74.
13. Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006; 27: 560-7.
14. Vogel U, Laros I, Jacobsen NR, et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 2004; 546: 65-74.
15. Zhou W, Liu G., Park S, et al. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 491-6.
16. Yin J, Vogel U, Guo L, et al. Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population. Cancer Genet Cytogenet 2006; 164: 66-70.
17. Matullo G., Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006; 27: 997-1007.
18. Zhou W, Liu G., Miller DP, et al. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002; 62: 1377-81.
19. Liang G., Xing D, Miao X, et al. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int J Cancer 2003; 105: 669-73.
20. Butkiewicz D, Rusin M, Enewold L, et al. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 2001; 22: 593-7.
21. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61: 1354-7.
22. Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002; 23: 599-603.
23. Misra R., Ratnasinghe D, Tangrea JA, et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 2003; 191: 171-8.
24. Shen M, Berndt SI, Rothman N, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 2005; 116: 768-73.
25. David-Beabes G.L, Lunn RM, London SJ. No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 911-2.
26. Chen S, Tang D, Xue K, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 2002; 23: 1321-5.
27. Park JY, Lee SY, Jeon HS, et al. Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer 2002; 36: 15-6.
28. Harms C, Salama SA, Sierra-Torres CH, et al. Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 2004; 44: 74-82.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
30. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
31. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665-7.
32. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
33. Egger M, Davey SG., Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
34. Sutton AJ, Duval SJ, Tweedie RL, et al. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000; 320: 1574-7.
35. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194-210.
36. Livneh Z. DNA damage control by novel DNA polymerases: translesion replication and mutagenesis. J Biol Chem 2001; 276: 25639-42.
37. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000; 92: 874-97.
38. Wei Q, Cheng L, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000; 92: 1764-72.
39. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996; 56: 4103-7.
40. Rajaee-Behbahani N, Schmezer P, Risch A, et al. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer 2001; 95: 86-91.
41. Li L, Lu X, Peterson CA, Legerski RJ. An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol Cell Biol 1995; 15: 5396-402.
42. Sugasawa K, Ng JM, Masutani C, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998; 2: 223-32.
43. Reardon JT, Nichols AF, Keeney S, et al. Comparative analysis of binding of human damaged DNA-binding protein (XPE) and Escherichia coli damage recognition protein (UvrA) to the major ultraviolet photoproducts: T(c,s)T, T(t,s)T, T(6-4)T, and T(Dewar)T. J Biol Chem 1993; 268: 21301-8.
44. Wakasugim M, Shimizum M, Moriokam H, et al. Damaged DNA-binding protein DDB stimulates the excision of cyclobutane pyrimidine dimers in vitro in concert with XPA and replication protein A. J Biol Chem 2001; 276: 15434-40.
45. Butkiewicz D, Rusin M, Harris CC, Chorazy M. Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population. Hum Mutat 2000; 15: 577-8.
46. Kozak M. Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 1996; 7: 563-74.
47. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58: 604-8.
48. Yu JJ, Mu C, Lee KB, et al. A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues. Mutat Res 1997; 382: 13-20.
49. Coin F, Bergmann E, Tremeau-Bravard A, Egly JM. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J 1999; 18: 1357-66.
50. Hu Z, Wei Q, Wang X, Shen H. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer 2004; 46: 1-10.
51. Benhamou S, Sarasin A. ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 2005; 161: 1-14.
52. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Ann Rev Biochem 1996; 65: 101-33.
53. Sijbers AM, de Laat WL, Ariza RR, et al. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 1996; 86: 811-22.
54. Smith TR, Levine EA, Perrier ND, et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 1200-4.
55. Fan F, Liu C, Tavare S, Arnheim N. Polymorphisms in the human DNA repair gene XPF. Mutat Res 1999; 406: 115-20.
56. Jeon HS, Kim KM, Park SH, et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003; 24: 1677-81.
57. Cui Y, Morgenstern H, Greenland S, et al. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer 2006; 118: 714-20.
58. Duell EJ, Wiencke JK, Chen TJ, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000; 21: 965-71.
59. Matullo G., Peluso M, Polidoro S, et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 2003; 12: 674-7.
60. Palli D, Russo A, Masala G., et al. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int J Cancer 2001; 94: 121-7.
61. Kozak M. Role of ATP in binding and migration of 40S ribosomal subunits. Cell 1990; 22: 459-67.
62. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 1999; 234: 187-208.
63. Kozak M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc Natl Acad Sci (USA) 1995; 92: 2662-6.
64. Tanaka K, Miura N, Satokata I, et al. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain. Nature 1990; 348: 73-6.
65. Sarasin A. An overview of the mechanisms of mutagenesis and carcinogenesis. Mutat Res 2003; 544: 99-106.
66. Wacholder S, Chanock S, Garcia-Closas M, et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96: 434-42.
67. Khoury M, Beaty TH, Cohen BH. () Fundamentals of Genetic Epidemiology. Monographs in Epidemiology and Biostatistics. New York: Oxford University Press; 1993.
68. Hoh J, Wille A, Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res 2001; 11: 2115-9.
69. Kiyohara C, Otsu A, Shirakawa T, et al. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 2002; 37: 241-56.